Singapore markets open in 6 hours 29 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,059.54 +41.15 (+0.82%) Dow
38,191.92 +288.63 (+0.76%) Nasdaq
15,818.25 +212.77 (+1.36%) Bitcoin USD
59,102.70 +1,135.71 (+1.96%) CMC Crypto 200
1,277.37 +6.63 (+0.52%)
GSK Jan 2025 45.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:52PM EDT. Market open.
| Previous close | 1.9900 |
| Open | 1.8500 |
| Bid | 2.2500 |
| Ask | 2.4000 |
| Strike | 45.00 |
| Expiry date | 2025-01-17 |
| Day's range | 1.8000 - 1.9900 |
| Contract range | N/A |
| Volume | |
| Open interest | 3.24k |
Simply Wall St.GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
BenzingaGSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in International and European markets. Shingrix sales reached 945 million Pounds, up 18% at constant currency, with Arexvy sales of 182 million Pounds. Specialty Medicine sales increased 17% to 2.5 billion poun
PA Media: MoneyGSK raises profit guidance as vaccine demand grows
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
© 2024 Yahoo. All rights reserved.